Chronic kidney disease and peripheral nerve function in the Health, Aging and Body Composition Study.
chronic kidney disease
motor
peripheral nerve
sensory
Journal
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
ISSN: 1460-2385
Titre abrégé: Nephrol Dial Transplant
Pays: England
ID NLM: 8706402
Informations de publication
Date de publication:
01 04 2019
01 04 2019
Historique:
received:
01
01
2018
pubmed:
15
5
2018
medline:
7
1
2020
entrez:
15
5
2018
Statut:
ppublish
Résumé
Chronic kidney disease (CKD) is associated with poor mobility. Peripheral nerve function alterations play a significant role in low mobility. We tested the hypothesis that early CKD is associated with altered sensory, motor and autonomic nerve function. Participants in the Health, Aging and Body Composition cohort who had kidney function measures in Year 3 (1999-2000) and nerve function measurements at Year 4 (2000-01) were analyzed (n = 2290). Sensory (vibration threshold, monofilament insensitivity to light and standard touch), motor [compound motor action potentials (CMAPs), nerve conduction velocities (NCVs)] and autonomic (heart rate response and recovery after a 400-m walk test) nerve function as well as participant characteristics were compared across cystatin C- and creatinine-based estimated glomerular filtration rate categorized as ≤60 (CKD) or >60 mL/min/1.73 m2 (non-CKD). The association between CKD and nerve function was examined with logistic regression adjusted for covariates. Participants with CKD (n = 476) were older (77 ± 3 versus 75 ± 3 years; P < 0.05) and had a higher prevalence of diabetes (20.6% versus 13.1%; P < 0.001). CKD was associated with higher odds for vibration detection threshold {odds ratio [OR] 1.7 [95% confidence interval (CI) 1.1-2.7]} and light touch insensitivity [OR 1.4 (95% CI 1.1-1.7)]. CMAPs and NCVs were not significantly different between CKD and non-CKD patients. In adjusted analyses, participants with CKD had higher odds of an abnormal heart rate response [OR 1.6 (95% CI 1.1-2.2)] and poor heart rate recovery [OR 1.5 (95% CI 1.1-2.0)]. CKD is associated with changes in sensory and autonomic nerve function, even after adjustment for demographics and comorbidities, including diabetes. Longitudinal studies in CKD are needed to determine the contribution of nerve impairments to clinically important outcomes.
Sections du résumé
BACKGROUND
Chronic kidney disease (CKD) is associated with poor mobility. Peripheral nerve function alterations play a significant role in low mobility. We tested the hypothesis that early CKD is associated with altered sensory, motor and autonomic nerve function.
METHODS
Participants in the Health, Aging and Body Composition cohort who had kidney function measures in Year 3 (1999-2000) and nerve function measurements at Year 4 (2000-01) were analyzed (n = 2290). Sensory (vibration threshold, monofilament insensitivity to light and standard touch), motor [compound motor action potentials (CMAPs), nerve conduction velocities (NCVs)] and autonomic (heart rate response and recovery after a 400-m walk test) nerve function as well as participant characteristics were compared across cystatin C- and creatinine-based estimated glomerular filtration rate categorized as ≤60 (CKD) or >60 mL/min/1.73 m2 (non-CKD). The association between CKD and nerve function was examined with logistic regression adjusted for covariates.
RESULTS
Participants with CKD (n = 476) were older (77 ± 3 versus 75 ± 3 years; P < 0.05) and had a higher prevalence of diabetes (20.6% versus 13.1%; P < 0.001). CKD was associated with higher odds for vibration detection threshold {odds ratio [OR] 1.7 [95% confidence interval (CI) 1.1-2.7]} and light touch insensitivity [OR 1.4 (95% CI 1.1-1.7)]. CMAPs and NCVs were not significantly different between CKD and non-CKD patients. In adjusted analyses, participants with CKD had higher odds of an abnormal heart rate response [OR 1.6 (95% CI 1.1-2.2)] and poor heart rate recovery [OR 1.5 (95% CI 1.1-2.0)].
CONCLUSIONS
CKD is associated with changes in sensory and autonomic nerve function, even after adjustment for demographics and comorbidities, including diabetes. Longitudinal studies in CKD are needed to determine the contribution of nerve impairments to clinically important outcomes.
Identifiants
pubmed: 29757410
pii: 4995012
doi: 10.1093/ndt/gfy102
pmc: PMC6452189
doi:
Substances chimiques
CST3 protein, human
0
Cystatin C
0
Creatinine
AYI8EX34EU
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, N.I.H., Intramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
625-632Subventions
Organisme : NIDDK NIH HHS
ID : K23 DK102824
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG024827
Pays : United States
Informations de copyright
© The Author(s) 2018. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.
Références
Clin Neurophysiol. 2006 May;117(5):992-9
pubmed: 16516547
Diabet Med. 2002 May;19(5):377-84
pubmed: 12027925
J Ren Care. 2010 May;36 Suppl 1:54-60
pubmed: 20586900
Am J Kidney Dis. 2012 Dec;60(6):912-21
pubmed: 22770927
N Engl J Med. 2012 Jul 5;367(1):20-9
pubmed: 22762315
PLoS One. 2016 Apr 27;11(4):e0154654
pubmed: 27119372
Diabetes Care. 2004 Jul;27(7):1591-7
pubmed: 15220233
Clin J Am Soc Nephrol. 2008 Mar;3(2):505-21
pubmed: 18184879
Clin J Am Soc Nephrol. 2013 Feb;8(2):313-8
pubmed: 23037984
Kidney Int. 2013 Jun;83(6):1029-41
pubmed: 23325084
Am J Kidney Dis. 2015 May;65(5):737-47
pubmed: 25542415
Nephrol Dial Transplant. 2013 Jan;28(1):48-54
pubmed: 23139404
Clin Exp Nephrol. 2016 Aug;20(4):650-659
pubmed: 26511876
Arch Phys Med Rehabil. 2016 Jan;97(1):45-52
pubmed: 26343170
Clin Neurophysiol. 2013 Mar;124(3):603-9
pubmed: 23022036
J Am Soc Nephrol. 2010 Sep;21(9):1560-70
pubmed: 20616169
J Neurol Neurosurg Psychiatry. 1981 Feb;44(2):121-8
pubmed: 7217967
Nephrol Dial Transplant. 2003 Feb;18(2):318-25
pubmed: 12543887
Clin Neurophysiol. 2017 Jan;128(1):281-286
pubmed: 27743880
Neurology. 1976 Feb;26(2):152-61
pubmed: 176611
Diabetes Metab Syndr. 2015 Oct-Dec;9(4):373-8
pubmed: 25470637
Clin J Am Soc Nephrol. 2017 Oct 6;12(10):1569-1577
pubmed: 28893921
N Engl J Med. 1971 May 27;284(21):1170-5
pubmed: 4324615
Clin Geriatr Med. 2008 Aug;24(3):407-35, v
pubmed: 18672180
J Am Geriatr Soc. 2015 Jul;63(7):1348-54
pubmed: 26096803
Nat Clin Pract Endocrinol Metab. 2008 Mar;4(3):164-72
pubmed: 18212763
J Nephrol. 2014 Feb;27(1):81-6
pubmed: 24519866
J Diabetes Res. 2016;2016:3425617
pubmed: 28058263
J Am Soc Nephrol. 2005 Jul;16(7):2127-33
pubmed: 15888561
Am J Phys Med Rehabil. 2008 Nov;87(11):921-8
pubmed: 18936557
J Am Geriatr Soc. 2014 Dec;62(12):2273-9
pubmed: 25482096
J Am Geriatr Soc. 2001 Nov;49(11):1544-8
pubmed: 11890597
J Am Geriatr Soc. 2004 Mar;52(3):405-10
pubmed: 14962156
Acta Med Scand. 1973 Nov;194(5):455-62
pubmed: 4757225
Am J Hypertens. 2011 Jul;24(7):755-61
pubmed: 21436791
Arch Intern Med. 2006 Jul 10;166(13):1396-402
pubmed: 16832005
Ann Intern Med. 2000 Apr 4;132(7):552-5
pubmed: 10744592
Diabetes Care. 2010 Oct;33(10):2285-93
pubmed: 20876709
Kidney Int. 2011 Jun;79(12):1370-8
pubmed: 21389978
Am J Transplant. 2013 Sep;13(9):2426-32
pubmed: 23841745
Neurobiol Aging. 2006 Aug;27(8):1145-54
pubmed: 16085338
J Diabet Complications. 1991 Jan-Mar;5(1):6-12
pubmed: 1856246
J Am Geriatr Soc. 2012 Jun;60(6):1057-63
pubmed: 22690982
J Am Soc Nephrol. 2013 Apr;24(5):822-30
pubmed: 23599380
J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):464-70
pubmed: 25320056
Curr Opin Nephrol Hypertens. 2013 Nov;22(6):615-23
pubmed: 24100215
J Am Geriatr Soc. 2009 Nov;57(11):2004-10
pubmed: 19793163
J Bone Miner Res. 2016 Apr;31(4):742-8
pubmed: 26590361
Hypertension. 2011 Apr;57(4):846-51
pubmed: 21300663
Aging Dis. 2015 Nov 27;7(4):466-78
pubmed: 27493833